文献速递前列腺癌

根治性前列腺切除术后早期挽救性放疗对持续升高或上升前列腺特异性抗原患者的影响

Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.
PubMed 文献 · Eur Urol · 2017-08-02

研究纳入7家机构925例淋巴结阴性根治性前列腺切除术后接受挽救性放疗的患者,中位随访8.0年,130例发生远处转移。多变量分析显示放疗前PSA水平与远处转移显著相关(风险比1.06,P<0.0001),回归树分析将患者分为5个风险组,早期挽救性放疗仅在低危、中危和高危三组中改善无转移生存。

要点

  • 放疗前PSA水平与远处转移显著相关,风险比1.06。
  • 回归树分析构建风险分层工具,曲线下面积85%。
  • 早期挽救性放疗仅对三个特定风险组有获益。

核心结论

  • 研究开发了准确的风险分层工具,基于前列腺癌特征促进早期挽救性放疗的个体化推荐。
  • 早期挽救性放疗仅对选定患者组有益,这些患者在挽救治疗时更可能受临床显著但尚未全身性复发的影响。

研究设计与样本

  • 研究纳入925例淋巴结阴性患者,在7家机构接受根治性前列腺切除术后挽救性放疗。
  • 患者因PSA上升或术后PSA持续(定义为术后1个月PSA水平≥0.1 ng/ml)接受挽救性放疗。
  • 所有患者接受前列腺和精囊床局部放疗。
  • 主要结局为挽救性放疗后远处转移,使用回归树分析开发风险分层工具,多变量Cox回归分析和非参数曲线拟合方法探索放疗前PSA水平与8年无转移生存概率的关系。

主要发现

  • 中位随访8.0年,130例患者发生远处转移。
  • 多变量分析中,放疗前PSA水平与远处转移显著相关(风险比1.06,P<0.0001)。
  • 回归树分析将患者分为5个风险组(曲线下面积85%),早期挽救性放疗仅在三个组中提供更好的无转移生存:(1)低危:根治性前列腺切除术后PSA不可测、Gleason评分≤7、肿瘤分期≥pT3b;(2)中危:根治性前列腺切除术后PSA不可测且Gleason评分≥8;(3)高危:根治性前列腺切除术后PSA持续且Gleason评分≤7。

关键数值与推荐

  • 放疗前PSA水平与远处转移的风险比1.06(P<0.0001)。
  • 回归树分析曲线下面积85%。
  • 风险分层:低危为根治性前列腺切除术后PSA不可测、Gleason评分≤7、肿瘤分期≥pT3b;中危为根治性前列腺切除术后PSA不可测且Gleason评分≥8;高危为根治性前列腺切除术后PSA持续且Gleason评分≤7。

临床怎么用

  • 作者认为,基于前列腺癌特征的准确风险分层工具可促进早期挽救性放疗的个体化推荐。
  • 作者认为,早期挽救性放疗仅对选定患者组有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Salvage radiation therapy (SRT) is a recommended treatment option for biochemical recurrence after radical prostatectomy (RP). However, its effectiveness may be limited to specific categories of patients. OBJECTIVE: We aimed to identify the optimal candidates for early SRT after RP. DESIGN, SETTING, AND PARTICIPANTS: The study included 925 node-negative patients treated with SRT after RP at seven institutions. Patients received SRT for either prostate-specific antigen (PSA) rising, or PSA persistence after RP that was defined as PSA level ≥0.1 ng/ml at 1 mo after surgery. All patients received local radiation to the prostate and seminal vesicle bed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome measured was distant metastasis after SRT. Regression tree analysis was used to develop a risk-stratification tool. Multivariable Cox regression analysis and nonparametric curve fitting methods were used to explore the relationship between PSA level at SRT and the probability of metastasis-free survival at 8 yr. RESULTS AND LIMITATIONS: At a median follow-up of 8.0 yr, 130 patients developed distant metastasis. At multivariable analysis, pre-SRT PSA level was significantly associated with distant metastasis (hazard ratio: 1.06, p<0.0001). However, when patients were stratified into five risk groups using regression tree analysis (area under the curve: 85%), early SRT administration provided better metastasis-free survival in three groups only: (1) low risk: undetectable PSA after RP, Gleason score ≤7, and tumour stage ≥pT3b, (2) intermediate risk: undetectable PSA after RP with Gleason score ≥8, (3) high risk: PSA persistence after RP with Gleason score ≤7. CONCLUSIONS: We developed an accurate risk stratification tool to facilitate the individualised recommendation for early SRT based on prostate cancer characteristics. Early SRT proved to be beneficial only in selected groups of patients who are more likely to be affected by clinically significant but not yet systemic recurrence at the time of salvage treatment administration. PATIENT SUMMARY: In patients affected by prostate cancer recurrence after radical prostatectomy, the early administration of salvage radiation therapy is beneficial only for selected subgroups of patients. In this study, these groups of patients were identified.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Fossati N, Karnes RJ, Colicchia M, et al. Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. Eur Urol. 2017. PMID: 28779974. doi:10.1016/j.eururo.2017.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。